GlassScriptPhysician profile
Subhakar Mutyala
NPI 1851472286
$11,554.84
in general payments reported to CMS, 2019-2025
46 companies · $760 in 2025
The $760 reported for 2025 was more than what 80% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $813 · 2020: $369 · 2022: $7,086 · 2023: $854 · 2024: $1,672 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777 · Honoraria: $900 · Consulting Fee: $525 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.63 |
| Honoraria | $900.00 |
| Consulting Fee | $525.00 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $7,323.85 | 2019-2025 | Imfinzi, Lynparza, Tagrisso |
| Abbvie INC. | $631.72 | 2019-2025 | |
| Bard Peripheral Vascular, INC. | $550.00 | 2023 | |
| Teleflex LLC | $360.45 | 2025 | Barrigel |
| Abbott Laboratories | $305.92 | 2019-2020 | |
| Pfizer INC. | $162.16 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $160.44 | 2019-2024 | Fruzaqla, Iclusig |
| Progenics Pharmaceuticals, INC. | $152.99 | 2022-2024 | Pylarify |
| Janssen Biotech, INC. | $150.51 | 2019-2025 | Talvey, Tecvayli, Carvykti |
| Janssen Scientific Affairs, LLC | $141.06 | 2022 | |
| Siemens Medical Solutions USA, INC. | $137.67 | 2024 | Truebeam, Halcyon |
| Bayer Healthcare Pharmaceuticals INC. | $133.14 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $127.20 | 2024-2025 | |
| Daiichi Sankyo INC. | $95.84 | 2019-2024 | Enhertu |
| Elekta, INC. | $84.00 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhakar Mutyala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.